Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. T. N. Lee, A. Peacock, M. Johnson (Glasgow, United Kingdom). The prognostic value of percent predicted six-minute walk distance in pulmonary arterial hypertension. Eur Respir J 2009; 34: Suppl. 53, 166

Member's Comments

No comment yet.

Related content which might interest you: The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension Source: Eur Respir J 2010; 36: 1294-1301 Year: 2010 The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension Source: Eur Respir Rev 2013; 22: 487-494 Year: 2013 The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Source: Eur Respir J 2004; 23: 28-33 Year: 2004 6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1823-1824 Year: 2014 6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1822-1823 Year: 2014 The 6-minute walk test adjusted for peak heart rate correlates with stroke volume index in pulmonary arterial hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Percent-predicted incremental shuttle walking test distance stratifies risk in pulmonary arterial hypertension Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Role of exercise cardiac index to predict NYHA functional class, 6-minute walk test distance and survival in idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1421-1429 Year: 2014 Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 The clinical relevance of heart rate increase in the interpretation of six-minute walk test in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Percent predicted six-minute walk distance and prognosis in PAH Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Prognostic value of predicted 6MWD in PAH Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods Year: 2015 Prognostic impact of oxygen saturation during the 6-minute walk test in pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Physiological response to the six-minute walk test in pulmonary arterial hypertension Source: Eur Respir J 2005; 26: 667-672 Year: 2005 FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change Source: Eur Respir J, 55 (5) 1902151; 10.1183/13993003.02151-2019 Year: 2020 Spiroveloergometry and 6-minute walking test for exercise capacity assessment in patients with primary pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 16s Year: 2005 Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension Source: Eur Respir J 2012; 40: 1410-1419 Year: 2012 Absolute 6-minute walk distance introduces a selection bias in pulmonary hypertension studies Source: Eur Respir J 2006; 28: Suppl. 50, 384s Year: 2006